Concepedia

Elias Carvalho Padilha

EC

Statistics

Publications

16

Citations

421

H-Index

13

Active since

2014

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

Universidade Estadual Paulista (Unesp)

Centro Universitário de Araraquara

Universidade Federal do Amapá

Elias Carvalho Padilha is an author at National Center for Advancing Translational Sciences specializing in pharmacology, medicine, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2014–2023

16

Publications

16

Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors

Ashish Thakur, Gregory J. Tawa, Mark J. Henderson et al. · Journal of Medicinal Chemistry · 2020 · 85 citations · Full text

Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties

Ganesha Rai, Daniel J. Urban, Bryan T. Mott et al. · Journal of Medicinal Chemistry · 2020 · 57 citations · Full text

Evaluation of Antimalarial Activity and Toxicity of a New Primaquine Prodrug

Marcelo Gomes Davanço, Anna Caroline Campos Aguiar, Leandro Alves dos Santos et al. · PLoS ONE · 2014 · 50 citations · Full text

, , +14

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment

Amy Q. Wang, Natalie R. Hagen, Elias Carvalho Padilha et al. · Frontiers in Pharmacology · 2022 · 28 citations · Full text

Human topoisomerase inhibition and DNA/BSA binding of Ru(II)–SCAR complexes as potential anticancer candidates for oral application

Rone Aparecido De Grandis, Mariana S. de Camargo, Monize M. da Silva et al. · BioMetals · 2017 · 26 citations · Full text

, , +8

Rows per page

1–5 of 16